BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8722337)

  • 1. Allogeneic transplantation for hematological malignancies using rho G-CSF mobilized blood stem cells.
    Azevedo WM; Aranha FJ; Gouvea JV; Vigorito AC; Marques JF; Eid KA; Azevedo AM; Barbosa KB; Souza CA
    Bone Marrow Transplant; 1996 Mar; 17 Suppl 2():S54-5. PubMed ID: 8722337
    [No Abstract]   [Full Text] [Related]  

  • 2. Transplantation of allogeneic peripheral blood stem cells.
    Bensinger WI; Buckner CD; Demirer T; Storb R; Appelbaum FA
    Bone Marrow Transplant; 1996 Mar; 17 Suppl 2():S56-7. PubMed ID: 8722338
    [No Abstract]   [Full Text] [Related]  

  • 3. [A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases].
    Chen Y; Huang X; Xu L; Liu D; Zhang Y; Ren H; Guo N; Lu D
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1306-9. PubMed ID: 12509932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic graft-versus-host disease after granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation: the role of donor T-cell dose and differentiation.
    MacDonald KP; Rowe V; Filippich C; Johnson D; Morris ES; Clouston AD; Ferrara JL; Hill GR
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):373-85. PubMed ID: 15148491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady-state marrow.
    Elfenbein GJ; Sackstein R
    Exp Hematol; 2004 Apr; 32(4):327-39. PubMed ID: 15050742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term engraftment, graft-vs.-host disease, and immunologic reconstitution after experimental transplantation of allogeneic peripheral blood cells from G-CSF-treated donors.
    Pan L; Bressler S; Cooke KR; Krenger W; Karandikar M; Ferrara JL
    Biol Blood Marrow Transplant; 1996 Oct; 2(3):126-33. PubMed ID: 9199755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation model.
    Hartung G; Zeis M; Glass B; Dreger P; Steinmann J; Schmitz N; Uharek L
    Bone Marrow Transplant; 2003 Jul; 32(1):49-56. PubMed ID: 12815478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular mechanism for granulocyte-colony stimulating factor in the prevention of graft-versus-host disease in combined bone marrow and peripheral blood transplantation for hematological malignancies: the composition in collection.
    Zhang C; Zhang X; Chen XH
    Transfus Apher Sci; 2013 Feb; 48(1):3-9. PubMed ID: 23279971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of accessory cells in allogeneic peripheral blood stem cell transplantation.
    Tanaka J; Imamura M; Kasai M; Asaka M; Torok-Storb B
    Int J Hematol; 1999 Feb; 69(2):70-4. PubMed ID: 10071453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined transplantation of G-CSF primed allogeneic bone marrow cells and peripheral blood stem cells in treatment of severe aplastic anemia.
    Huang XJ; Chen YH; Xu LP; Zhang YC; Liu DH; Guo NL; Lu DP
    Chin Med J (Engl); 2004 Apr; 117(4):604-7. PubMed ID: 15109458
    [No Abstract]   [Full Text] [Related]  

  • 12. Transplantation of allogeneic CD34+ peripheral blood stem cells (PBSC) in patients with advanced hematologic malignancy.
    Bensinger WI; Buckner CD; Rowley S; Demirer T; Storb R; Appelbaum FA
    Bone Marrow Transplant; 1996 Mar; 17 Suppl 2():S38-9. PubMed ID: 8722333
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Ringdén O; Labopin M; Gorin NC; Le Blanc K; Rocha V; Gluckman E; Reiffers J; Arcese W; Vossen JM; Jouet JP; Cordonnier C; Frassoni F
    J Clin Oncol; 2004 Feb; 22(3):416-23. PubMed ID: 14691124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel approach to human leukocyte antigen-mismatched transplantation in patients with malignant hematological disease.
    Huang XJ; Han W; Xu LP; Chen YH; Liu DH; Lu J; Chen H; Zhang YC; Jiang Q; Liu KY; Lu DP
    Chin Med J (Engl); 2004 Dec; 117(12):1778-85. PubMed ID: 15603704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte colony-stimulating factor affects serum levels of soluble interleukin-2 receptors after allogeneic stem cell transplantation.
    Remberger M; Sundberg B
    Haematologica; 2005 Mar; 90(3):427-9. PubMed ID: 15749688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Allogeneic peripheral blood stem cell transplantation].
    Harada M
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1877-85. PubMed ID: 8978790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that donor intrinsic response to G-CSF is the best predictor of acute graft-vs-host disease following allogeneic peripheral blood stem cell transplantation.
    Dhédin N; Chamakhi I; Perreault C; Roy DC; Sauvageau G; Ducruet T; Busque L; Fish D; Bélanger R; Roy J
    Exp Hematol; 2006 Jan; 34(1):107-14. PubMed ID: 16413397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of hematopoietic growth factors on the risk of graft-vs-host disease after allogeneic hematopoietic stem cell transplantation: a meta-analysis.
    Ho VT; Mirza NQ; Junco Dd Dd; Okamura T; Przepiorka D
    Bone Marrow Transplant; 2003 Oct; 32(8):771-5. PubMed ID: 14520420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human granulocyte colony-stimulating factor (rh-G-CSF) may accelerate hematopoietic recovery after HLA-identical sibling allogeneic peripheral blood stem cell transplantation.
    Ozcan M; Ustün C; Akçağlayan E; Akan H; Arslan O; Ilhan O; Beksaç M; Gürman G; Demirer T; Arat M; Celebi H; Konuk N; Uysal A; Koç H
    Bone Marrow Transplant; 2001 Mar; 27(5):499-505. PubMed ID: 11313683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis.
    Bornhäuser M; Theuser C; Soucek S; Hölig K; Klingebiel T; Blau W; Fauser A; Runde V; Schwinger W; Rutt C; Ehninger G
    Haematologica; 2000 Aug; 85(8):839-47. PubMed ID: 10942931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.